Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

37.02

+0.91 (2.52%)

At close: Jun 10, 2026, 4:00 PM EDT

37.00

-0.02 (-0.05%)

After-hours: Jun 10, 2026, 4:04 PM EDT

Enliven Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	132.18	98.9	124.12	100.14	75.54	48.31
Short-Term Investments	320.22	363.73	189.32	153.01	-	41.97
Cash & Short-Term Investments	452.4	462.62	313.44	253.15	75.54	90.28
Cash Growth	56.24%	47.59%	23.82%	235.14%	-16.33%	2.33%
Other Current Assets	10.74	12.26	4.69	13	2.22	2.42
Total Current Assets	463.14	474.88	318.13	266.15	77.75	92.7
Net Property, Plant & Equipment	0.31	0.42	0.46	1.06	1.52	0.78
Other Long-Term Assets	1.41	0.87	7.18	4.65	4.03	0.18
Total Assets	464.85	476.17	325.76	271.87	83.3	93.65
Accounts Payable	1.64	2.16	1.34	0.53	3.44	2.36
Accrued Expenses	9.85	14.41	14.57	15.36	6.28	4.6
Current Portion of Leases	-	-	-	-	-	0.25
Other Current Liabilities	-	-	-	10	-	-
Total Current Liabilities	11.49	16.57	15.92	25.89	9.72	7.21
Long-Term Leases	-	-	-	-	-	0.41
Other Long-Term Liabilities	-	-	-	0.07	0.66	-
Total Long-Term Liabilities	-	-	-	0.07	0.66	0.41
Total Liabilities	11.49	16.57	15.92	25.96	10.37	7.62
Common Stock	0.06	0.06	0.05	0.04	0	0.03
Additional Paid-in Capital	824.48	806.37	553.21	400.17	6.04	233.52
Accumulated Other Comprehensive Income	-0.38	0.33	0.06	0.14	-	-0.02
Retained Earnings	-370.79	-347.17	-243.47	-154.45	-82.86	-147.5
Total Common Shareholders' Equity	453.37	459.6	309.85	245.91	-76.83	86.03
Minority Interest	-	-	-	-	149.75	-
Shareholders' Equity	453.37	459.6	309.85	245.91	72.92	86.03
Total Liabilities & Equity	464.85	476.17	325.76	271.87	83.3	93.65
Total Debt	-	0	0	0	0	0.65
Net Cash (Debt)	452.4	462.62	313.44	253.15	75.54	89.63
Net Cash Growth	-2.21%	47.59%	23.82%	235.14%	-15.72%	1.59%
Net Cash Per Share	7.57	8.16	6.66	7.12	24.18	25.75
Book Value	453.37	459.6	309.85	245.91	-76.83	86.03
Book Value Per Share	7.58	8.11	6.58	6.92	-24.59	24.71
Tangible Book Value	453.37	459.6	309.85	245.91	-76.83	86.03
Tangible Book Value Per Share	7.58	8.11	6.58	6.92	-24.59	24.71

SEC Filings: 10-K · 10-Q